FDA warns of deadly side effect with imaging drugs

Contrast agents containing the chemical gadolinium used in MRI scans can cause a rare and sometimes fatal syndrome in patients with kidney disease. Stronger warning labels are being added to the drugs.Federal health regulators are warning doctors that a class of injectable drugs used in MRI medical imaging scans can cause a rare and sometimes fatal condition in patients with kidney disease.

Read the whole article on LA Times - Science

More from LA Times - Science